Oral Presentation Details
A Randomized Clinical Trial of Three Doses of a Long-Acting Oral Direct Factor Xa Inhibitor Betrixaban in Patients With Atrial Fibrillation (Presentation #3015-12)
Presenter: Dr. Michael D. Ezekowitz
Session: Late-Breaking Clinical Trials II: Cardiac Arrhythmias
Date: Monday, March 15, 8:51-9:03 a.m. ET
Location: Georgia World Congress Center, Murphy Ballroom
Subscribe to our Free Newsletters!
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...
Unintended pregnancies are very common these days, and so one in about four pregnant women go for ...
Dizziness is a feeling of being faint or unsteady whereas Vertigo is a feeling that you or your ...View All